These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32130709)

  • 21. Metabolomics in chronic pain research.
    Teckchandani S; Nagana Gowda GA; Raftery D; Curatolo M
    Eur J Pain; 2021 Feb; 25(2):313-326. PubMed ID: 33065770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospects for clinical cancer metabolomics using stable isotope tracers.
    Lane AN; Fan TW; Higashi RM; Tan J; Bousamra M; Miller DM
    Exp Mol Pathol; 2009 Jun; 86(3):165-73. PubMed ID: 19454273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.
    Rankin NJ; Preiss D; Welsh P; Burgess KE; Nelson SM; Lawlor DA; Sattar N
    Atherosclerosis; 2014 Nov; 237(1):287-300. PubMed ID: 25299963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomic signature of brain cancer.
    Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
    Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postgenomics diagnostics: metabolomics approaches to human blood profiling.
    Trifonova O; Lokhov P; Archakov A
    OMICS; 2013 Nov; 17(11):550-9. PubMed ID: 24044364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMR-Based Prostate Cancer Metabolomics.
    Euceda LR; Andersen MK; Tessem MB; Moestue SA; Grinde MT; Bathen TF
    Methods Mol Biol; 2018; 1786():237-257. PubMed ID: 29786797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of molecular phenotyping approaches in the personalized surgical patient journey.
    Mirnezami R; Kinross JM; Vorkas PA; Goldin R; Holmes E; Nicholson J; Darzi A
    Ann Surg; 2012 May; 255(5):881-9. PubMed ID: 22156927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR-Based Metabolomics.
    Nagana Gowda GA; Raftery D
    Adv Exp Med Biol; 2021; 1280():19-37. PubMed ID: 33791972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracer-Based Cancer Metabolomic Analysis.
    Liu J; Huang J; Xiao GG
    Adv Exp Med Biol; 2021; 1280():115-130. PubMed ID: 33791978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation.
    Abooshahab R; Gholami M; Sanoie M; Azizi F; Hedayati M
    Endocrine; 2019 Jul; 65(1):1-14. PubMed ID: 30937722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomics as a Critical Tool for Studying Clinical Surgery.
    Gao Z; Zhou W; Lv X; Wang X
    Crit Rev Anal Chem; 2024; 54(7):2245-2258. PubMed ID: 36592066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR-based metabolomics: from sample preparation to applications in nutrition research.
    Brennan L
    Prog Nucl Magn Reson Spectrosc; 2014 Nov; 83():42-9. PubMed ID: 25456316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomics and health: from nutritional crops and plant-based pharmaceuticals to profiling of human biofluids.
    Marchev AS; Vasileva LV; Amirova KM; Savova MS; Balcheva-Sivenova ZP; Georgiev MI
    Cell Mol Life Sci; 2021 Oct; 78(19-20):6487-6503. PubMed ID: 34410445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarker Discovery Using NMR-Based Metabolomics of Tissue.
    Grinde MT; Giskeødegård GF; Andreassen T; Tessem MB; Bathen TF; Moestue SA
    Methods Mol Biol; 2019; 2037():243-262. PubMed ID: 31463850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.
    Lin G; Chung YL
    Biomed Res Int; 2014; 2014():625095. PubMed ID: 24724090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of NMR-based metabolomics.
    Markley JL; Brüschweiler R; Edison AS; Eghbalnia HR; Powers R; Raftery D; Wishart DS
    Curr Opin Biotechnol; 2017 Feb; 43():34-40. PubMed ID: 27580257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of metabolomics technologies toward cancer prognosis and therapy.
    Hoang G; Udupa S; Le A
    Int Rev Cell Mol Biol; 2019; 347():191-223. PubMed ID: 31451214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics as a tool for cardiac research.
    Griffin JL; Atherton H; Shockcor J; Atzori L
    Nat Rev Cardiol; 2011 Sep; 8(11):630-43. PubMed ID: 21931361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomics toward personalized medicine.
    Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
    Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.